We have accepted an invitation from Slovak television TA3 to discuss prostate cancer, which is one of the most common oncological diseases among men in Slovakia.
Dr. Boris Kollarik, key expert in urology of the Slovak Ministry of Healthcare presented its incidence, current diagnostic and therapeutic methods, as well as the screening program to be launched in Slovakia soon. Our CEO Eva Kovacova FCCA also introduced a new blood based test developed by Glycanostics – Giasay® Prostate Cancer Test that is already available for patients in Slovakia and provides the most accurate results from the tests currently available. It serves as a second opinion test to provide additional information to patients and their urologists even before MRI scan or prostate biopsy.
We have also shared great news related to our ongoing CE mark certification process and plans to launch our test through laboratory chains in Slovakia, Austria and Germany already in 2025.
